Stockreport

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program [Yahoo! Finance]

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF SEATTLE, March 21, 2025 BUSINESS WIRE )--Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site activation for enrollment is underway for the company [Read more]